The impact of cetuximab on the capecitabine plus oxaliplatin (XELOX) combination in first-line treatment of metastatic colorectal cancer (MCC): A randomized phase II trial of the Swiss Group for Clinical Cancer Research (SAKK)

Markus Borner, A. Roth, Dieter Koeberle et al.|Journal of Clinical Oncology|2006

Cited by 26